{"title": "Nvidia ($NVDA) earns $1,98 per share (vs. $1.47 expected), yet falls in the after trading hours.", "selftext": "Why? It exceeded expected earnings by far, but still falls ~3%?", "id": "8iiqqk", "created_utc": 1525990211.0, "score": 190, "upvote_ratio": 0.94, "num_comments": 98, "comments": [{"body": "The stock shot up in anticipation of good earnings (11% over the last few days). In other words, it already increased substantially from an expected good earnings report. In order for it to increase more from a good earnings report, the report would have had to be ridiculously good. It\u2019s earnings were good, but not good enough to justify the 11% increase. So it adjusted in the  after hours ", "score": 138, "replies": [{"body": "EPS wasn't the right metric. More the P/E and P/B are what should be looked at. \n\n[Source](https://finviz.com/quote.ashx?t=nvda)", "score": 19, "replies": [{"body": "While I agree with you on the P/E, I'm curious as to why you feel P/B is so important in regards to a technology company? Not saying you're wrong, but would like to know your reasoning behind it. Personally, I tend to disregard P/B a bit more when in comes to tech, pharma, etc, etc, but if you have a strong reasoning I would love to change my ways.", "score": 6, "replies": [{"body": "\"There are companies with high book ratio but low earnings ratio showing the company not growing due to high paying dividend and slow growth like utilities companies etc. Both should be taken into account. However many uses P/E ratio as a quick guide to see if the current stock price is over or under value.\"\n\nLike you said, it depends on the sector. But if both P/E and P/B are low and break the norm, they deserve a second look. It's comparable to how Morning Star uses its \"overweight/underweight\" scale. Just different ways of looking at the same picture. ", "score": 2, "replies": [], "tickers": [], "relates_score": 0.5459676384925842}], "tickers": [], "relates_score": 0.4778708219528198}, {"body": "Generally, the magnitude of the beat versus expectations on the line items they guide for (to which Sell-side is a descent proxy for), drives stock reaction on a given quarter for NVDA. That is, segment revenues, and operating profit/EBITDA margins. Unless you have institutional investor access, it will be hard if not impossible for you to tell that the stock outperformed into the print because, say, Toshiya Hari from Goldman put out an email blast to his clients highlighting strong channel checks which suggested more upside in gaming segment, driven by crypto GPU buying (ie Gaming segment rev expectations going up incrementally \n), for example.", "score": 2, "replies": [], "tickers": ["nvda"], "relates_score": null}], "tickers": ["nvda"], "relates_score": null}, {"body": "So you're saying the $1.47 expected EPS wasn't really expected, but people really expected higher EPS (even higher than $1.98)?", "score": 13, "replies": [{"body": "Lots of people/organization bought in weeks and months ago. They have seen at least a 11% return on investment in a short period of time. No reason not to take big profits now and buy back in after the sell off over the next few weeks. ", "score": 8, "replies": [], "tickers": [], "relates_score": 0.3060755729675293}, {"body": "That\u2019s the typical way Nvidia has worked thus far. If you remember around late July or August of 2017, they released record breaking earnings, but because people expected them to beat estimates even more, they plummeted from the $180\u2019s range to around $138 over about two days. Also, it\u2019s especially important to realize that with so much growth in their stock price and a very high P/E ratio, any slightly bad news could be detrimental to a high flying growth stock", "score": 3, "replies": [{"body": "Yea I\u2019ve been holding Nvidia for a while now and this happens every time. Run up to earnings then a good beat. Then the stock falls a bit and trades sideways until the next run up to earnings. Rinse and repeat. ", "score": 4, "replies": [{"body": "Yeah I\u2019ve had the same exact experience. Although their stock is very volatile and doesn\u2019t always move rationally, my plan is to just stay in there because I believe it\u2019s a pretty good long term investment", "score": 5, "replies": [], "tickers": [], "relates_score": 0.575472891330719}], "tickers": ["nvda"], "relates_score": null}], "tickers": ["nvda"], "relates_score": null}, {"body": "No, look at a two week chart the beat was priced in.  Nvda was trading at 217ish a month ago.", "score": 1, "replies": [{"body": "but it was down on sector underperformance/market volatility", "score": 1, "replies": [{"body": "lol hi, it was down at that time d/t crypto mining reform fears, after the uber crash ai autonomous demand wane fears, etc, there was some sector and market trends but there were real concerns and everyone expected toppy earnings, it went from 215 to like 255 the week before earnings, it wasn't going to pop from the beat... ppppp riced innnnnnn", "score": 1, "replies": [{"body": "not completely disagreeing.  a fair amount of that was an overreaction, where it was pulled below the trend ", "score": 1, "replies": [{"body": "I had played the move before that, another 215 to 240 in april, I wish I would have done it again but earnings started weird d/t that cat \"top\" comment and I hesitated :( ", "score": 2, "replies": [], "tickers": [], "relates_score": 0.30650246143341064}], "tickers": [], "relates_score": 0.45985540747642517}], "tickers": ["crash"], "relates_score": null}], "tickers": [], "relates_score": 0.6072945594787598}], "tickers": ["nvda"], "relates_score": null}], "tickers": [], "relates_score": 0.3028061091899872}, {"body": "I used to try to play earnings but this little tidbit of information flew by me the first several times. Definitely gotta watch that pre earnings move ", "score": 1, "replies": [], "tickers": [], "relates_score": 0.4674127697944641}, {"body": "The only REAL research out there that helps decision making is done by tastytrade. Options trades based on upcoming earnings taking advantage of volatility crush have a 50% probability.", "score": 1, "replies": [], "tickers": [], "relates_score": 0.19636809825897217}, {"body": "The earnings were about as good as it gets. What more could they have possibly done? ", "score": -1, "replies": [], "tickers": [], "relates_score": 0.4270690977573395}], "tickers": [], "relates_score": 0.4278145432472229}, {"body": "[deleted]", "score": 53, "replies": [{"body": "Then shouldn't it have been \"priced in\" into the estimation as well? Like, estimate higher than $1.47 per share?", "score": -10, "replies": [{"body": "The estimated higher EPS wasn't done yesterday. People knew the EPS would be higher that's why they bought more last few days. ", "score": 18, "replies": [{"body": "How to people generally find the consensus on estimated EPS before an earnings call? (Just wondering what sites I should be looking at for that kind of info)", "score": 1, "replies": [], "tickers": [], "relates_score": 0.34368547797203064}], "tickers": [], "relates_score": 0.5061548352241516}, {"body": "\u201cEstimated\u201d is the average sellside research firm estimate. Analysts don\u2019t change those daily, so a stock reaction like this means that the big institutional buyside players expected a beat of this magnitude, but the expected EPS on the sellside hadn\u2019t yet caught up. ", "score": 6, "replies": [], "tickers": [], "relates_score": 0.574558436870575}], "tickers": [], "relates_score": 0.04290549084544182}], "tickers": [], "relates_score": 0.08604494482278824}, {"body": "bc the 11% run up in the last 3 days wasn't good enough for you?", "score": 36, "replies": [{"body": "textbook buy the rumour sell the news", "score": 21, "replies": [], "tickers": [], "relates_score": 0.17061984539031982}, {"body": "I'm happy with the overall performance, but I don't understand why much-higher-than-expected EPS would result in the stock price falling. Do you? If so, would you mind sharing your expertise?", "score": -9, "replies": [{"body": "[deleted]", "score": 17, "replies": [{"body": "The stock shot up in anticipation of good earnings. In other words, it already increased substantially from good earnings. In order for it to increase more from a good earnings report, the report would have had to be ridiculously good. It\u2019s earnings were good, but not good enough to justify the 11% increase. So it adjusted in the  after hours ", "score": 8, "replies": [], "tickers": [], "relates_score": 0.028120052069425583}, {"body": "And then the earnings report came in, much higher than expected, which would make me expect a further increase in stock price, yet it dropped. Why?", "score": -15, "replies": [{"body": "It had a big run up, and people were probably expecting even better results than what were given. Bear in the mind the run up came from short term traders, who choose to sell after a good (but not moonshot level) earnings.", "score": 1, "replies": [], "tickers": [], "relates_score": 0.7479367852210999}, {"body": "Also, earnings that don't match estimates is a sign of bad management.", "score": 1, "replies": [], "tickers": [], "relates_score": 0.5166306495666504}, {"body": "Because people are selling their shares after the big run up in the last week moron.", "score": -14, "replies": [{"body": "No need to be rude, man.", "score": 11, "replies": [{"body": "You weren\u2019t getting it when people were being nice", "score": -7, "replies": [{"body": "Dude I agree. This guy is dense. How don\u2019t people understand this. ", "score": 2, "replies": [{"body": "because if NVDA was expected to beat earnings expectations it implies that whoever came up with the expectations either lowered them on purpose or was completely clueless about the widely expected outcome. Both are hard to accept, because it means the financial institutions are either unprofessional or corrupt.", "score": 1, "replies": [{"body": "No, their has been a lot of factors that affected their earnings that financial institutions knew about but couldnt exactly just out in to their expectations without evidence. Theres no real way to know the earnings before the company releases them and analysis have to work off past data which is not exactly accurate in a super volitiale cryptocurrency inflated tech market rn", "score": 2, "replies": [{"body": "I buy the argument that analysts have to put a lot of weigh on past performance in their models which is often a poor predictor for exponentially growing tech companies. So even though the company beats earnings it's old news for most because they know that earning predictions are biased to historical rates of growth.\n\nI think that's what's hard for [**aleqqqs**](https://www.reddit.com/user/aleqqqs) to grasp.", "score": 2, "replies": [], "tickers": [], "relates_score": 0.6495181918144226}], "tickers": [], "relates_score": 0.568623960018158}], "tickers": ["nvda"], "relates_score": null}], "tickers": [], "relates_score": 0.2519952356815338}], "tickers": [], "relates_score": 0.3470565974712372}], "tickers": [], "relates_score": 0.13971997797489166}], "tickers": [], "relates_score": 0.5452262759208679}], "tickers": [], "relates_score": 0.07311776280403137}], "tickers": [], "relates_score": 0.01854238659143448}, {"body": "it's up 8.39% in the last week even with the 3.43% ah decline. you can see the expectations of the stock in the last 3 days. we hit a 52 week high today. serious what are you looking for as an investor?", "score": 0, "replies": [{"body": "> what are you looking for as an investor?\n\nBesides money, obviously, I'm trying to understand what's happening. Thus my question how excelling expectations doesn't result in a rise in stock price, but a drop.\n\nAs I said, I'm not complaining, I'm genuinely curious because I don't understand.", "score": 6, "replies": [{"body": "Think of it like this. If the stock ran up to $300 and they exceeded expectations, would you still think the stock should go up more?\n\n\n\n", "score": 2, "replies": [], "tickers": [], "relates_score": 0.5900747179985046}, {"body": "Price of stock is percieved value and not an exact metric. Some people were content enough with their gains to warrant selling off to retain their profits. Enough people wanted to do this that the price of the stock dipped.", "score": 1, "replies": [], "tickers": [], "relates_score": 0.5010963678359985}], "tickers": [], "relates_score": 0.4608567953109741}], "tickers": [], "relates_score": 0.5285175442695618}], "tickers": [], "relates_score": 0.3593236804008484}], "tickers": [], "relates_score": 0.4782395660877228}, {"body": "P R I C E D I N -- EPS isn't everything", "score": 12, "replies": [], "tickers": [], "relates_score": 0.12528403103351593}, {"body": "Buy on rumor and sell on news.", "score": 9, "replies": [{"body": "how to apply that in this circunstances?", "score": 1, "replies": [{"body": "You do not hold through earnings is how.    But much more of a trader move.   I do invest for the long term and hold and do not lose sleep if the stock goes down for a day or a week or really even a month or two.  Well if I really believe in the company,\n\nMy dad invested in the market since he was very young.  His parents died when he was young and gave him a lot of money for the time and he started investing when he was in his low 20s.  But he would really never share much with me.\n\nBut will never forget a very, very long time ago I was invested into a company that was reporting.   He was watching one of our kids and just mentioned  how excited I was about this company reporting and going to kill it.   One of the few things he ever shared was said to me \"JR you buy on rumor and sell on news\".   I said it to my wife a few times what he said and was like what does it mean?   Sure enough they reported blow out numbers and the stock decline.   I looked at her and said well now I know what it means.\n\nMarket is irrational in the short term and efficient in the long term.  Nvidia does financially well long term and all will be good.\n\n", "score": 3, "replies": [{"body": "thx bro", "score": 3, "replies": [], "tickers": [], "relates_score": 0.0222722627222538}], "tickers": ["nvda"], "relates_score": null}], "tickers": [], "relates_score": 0.041611701250076294}], "tickers": [], "relates_score": 0.31309598684310913}, {"body": "I want to know if result is enough to move the general tech/overall market tomorrow? \n\nWe've had such a nice green week.", "score": 2, "replies": [], "tickers": [], "relates_score": 0.3521009683609009}, {"body": "\nOthers are mentioning market sentiment  or fundamental factors:  weather because of the over-buying prior to earnings or less than desired p/e respectively. \n\nHowever, I'm the doofus telling you it's actually the technical factors, and all these lamo-s are lost. I think there is a false notion that tech is very safe as an industry. \n\n* * *\n\nThe same thing used to be thought of a lot of the commodities, and then it was thought of real estate, and then it was thought of financials, and then real estate again, and then motor vehicles, and then it was kinda all up in the air for a while, **but** now we have the tech industry that is a \"safe bet no matter what\"--sort of cloud9 honeypot stock sector. I heard guys telling folks to split 50/25/25 on sector etfs, NVDA, AND this week. That's a really scary sign considering we haven't seen tech respond to much sector wide negative news yet, such as if Intel's 10nm process isn't a possibility, or if AMD EPYC chips don't actually do anything, or if Nvidia just *doesn't have* a lineup for after the 10xx series. I'm not saying there aren't other good manufacturers, and I'm not saying that we should all drink the Jonestown punch just because they did something weird around earnings--after an infinite green stretch. I'm just noting that there could be other factors, but I am not worried about it, NVDA will keep on keepin on. \n\n\n* * *\n\n[Here is an investopedia](https://www.investopedia.com/articles/basics/04/100804.asp) article  describing the differences in technical factors, fundamental factors, and market sentiment. ", "score": 2, "replies": [], "tickers": ["amd", "nvda", "intc", "nvda"], "relates_score": null}, {"body": "The beat was priced in. This is why you should sell rallies into ERs. ", "score": 2, "replies": [{"body": "Tell that to anyone who sold HEAR prior to the earnings report. Missed out on the 25%-40% flux wagon. Lol", "score": 1, "replies": [{"body": "You\u2019re comparing a company with a $200M market cap to one with a $150B market cap. Not comparable at all. \n\nWhat you\u2019re saying is gambling sometimes pays off, which it does. Large caps that rally into ERs typically sell off even on good reports. Look at MU last quarter.", "score": 1, "replies": [], "tickers": [], "relates_score": 0.4939629137516022}], "tickers": [], "relates_score": 0.5167994499206543}], "tickers": [], "relates_score": 0.4621506631374359}, {"body": "Meh, wait a week or so. $GOOG also fell after beating expectations.", "score": 2, "replies": [], "tickers": [], "relates_score": 0.5600499510765076}, {"body": "It could have a delayed response when people start looking at the overall metrics. I predict it will recover tomorrow but +2 to 5 percent.\n\nMain point of concern, 50%+ percent of profit from GPUs focused on crypto. One trick ponies work in biotech and pharma but tech manufacturing looks for diversity. They hold a lion-share of the pie but AMD finally is turning it around with good management decisions.\n\n[Source] (https://www.reuters.com/article/us-nvidia-results/chipmaker-nvidias-stock-falls-on-data-center-miss-idUSKBN1IB2X8)", "score": 4, "replies": [{"body": "> I predict it will recover tomorrow but +3 to 7 percent.\n\nHmm. Repeatedly being correct with predictions like this one would make you one hell of a daytrader. Are you?", "score": 4, "replies": [{"body": "No, I own NVDA stock and it helps me sleep better at night. Plus having a diverse portfolio as well\n\nAnd it's finals week. Anything but studying, right?\n\nPredictions with specific numbers are a gamble but better than the \"i told you so\" method if it happens. ", "score": 2, "replies": [{"body": "Upvoted for \"anything but studying\" amen brother, got done last week good luck!", "score": 3, "replies": [{"body": "Looks like I was wrong. I didn\u2019t realize but the \u201cafter hours earnings\u201d has the stock starting the day in the red. Lol\n\nHad I known that, that estimate would have been scaled back the 3% it dropped. Damn, TIL", "score": 1, "replies": [], "tickers": [], "relates_score": 0.06065402925014496}], "tickers": [], "relates_score": 0.252007395029068}], "tickers": ["nvda"], "relates_score": null}], "tickers": [], "relates_score": 0.6476911902427673}, {"body": "> AMD finally is turning it around with good management decisions.\n\nPeople have been saying this forever, but I still dont see any results.\n", "score": 3, "replies": [{"body": "Yes and no, depends on what you're looking at. Looking solely at net income, gross profit and operating income, I do believe it has started to turn around. I'd prefer 2-3 consistent quarters but yes.\n\n[Source] (https://www.nasdaq.com/symbol/amd/financials?query=income-statement&data=quarterly) ", "score": 1, "replies": [], "tickers": ["amd"], "relates_score": null}], "tickers": ["amd"], "relates_score": null}], "tickers": ["nvda", "amd"], "relates_score": null}, {"body": "I'm so glad I got a piece of it back in  March 2016", "score": 3, "replies": [{"body": "[deleted]", "score": 14, "replies": [{"body": "Nice !", "score": 1, "replies": [{"body": "Sold that shot over inflated and made just as much off it as I have off trading nvidia stock volatility in the last few months ", "score": 2, "replies": [{"body": "That's crazy, did you have some action with AMD?", "score": 2, "replies": [{"body": "Yeah actaully had about 10 shares the first time it jumped from 10ish to 12ish. Sold and wanted to get back in on this last stretch where it was around 10 but my money was tied up waiting for other stuff, mainly in nvidia which I sold around 248 this week. Now I'm waiting for nvidia new gpu line to come out and make amds stock go down a little bit to buy a shitload of amd ", "score": 1, "replies": [{"body": "I acquire AMD during the same time I acquire NVIDIA, which back in march it started at 2.52. It's at 12.13 and I want to keep holding on to it to see what 2019 has to offer", "score": 1, "replies": [{"body": "Holy duck yeah you're good hold, I dont think 12 is currently a fair price for it simply based off my tech background and the fact that up until this year if you build a pc with an amd card you got made fun of... but now people actaully consider them and I actaully did when I just bought a new GPU but I was actaully able to find a really good nvidia for very close to msrp sp I took that instead. But I'll tell you amd has changed the mind of gamers on their gpus sp they stand a solid chance in that part of their business", "score": 2, "replies": [{"body": "There's a big hype and change being done in how GPU gaming is achieve, and AMD is making a pretty big come up with their products. At the end of the day I want to see what other products I can also invest in to be able to make a solid profit within the next couple years.", "score": 1, "replies": [{"body": "By products that you can invest in what do you mean?", "score": 1, "replies": [{"body": "For example Corsair, Logitech, EVGA, basically parts.", "score": 1, "replies": [{"body": "You think their value will go up?", "score": 1, "replies": [{"body": "I can't really say. With NVIDIA and AMD it was much clear to acquire the buy due to the amount of hype both companies had. Have to be more attentive to these companies", "score": 1, "replies": [], "tickers": ["amd", "nvda"], "relates_score": null}], "tickers": [], "relates_score": 0.1527663767337799}], "tickers": [], "relates_score": 0.36291125416755676}], "tickers": [], "relates_score": 0.4361981153488159}], "tickers": ["amd"], "relates_score": null}], "tickers": ["nvda", "amd"], "relates_score": null}], "tickers": ["nvda", "amd"], "relates_score": null}], "tickers": ["amd", "nvda"], "relates_score": null}], "tickers": ["amd"], "relates_score": null}], "tickers": ["nvda"], "relates_score": null}], "tickers": [], "relates_score": 0.1431446075439453}], "tickers": [], "relates_score": 0.074761301279068}, {"body": "Ditto! Bought it a couple years ago and up 300+%, it\u2019s awesome", "score": 2, "replies": [], "tickers": [], "relates_score": 0.43053603172302246}], "tickers": [], "relates_score": 0.21881051361560822}, {"body": "[Here](https://twitter.com/crypto/status/994719693847097346?s=21) you go. ", "score": 1, "replies": [], "tickers": [], "relates_score": 0.09118634462356567}, {"body": "watching out for profit pullers before the weekend", "score": 1, "replies": [], "tickers": [], "relates_score": 0.2710523307323456}, {"body": "Was the 1.98 a clean number. Wow that's a big beat. Jeez this company doesn't stop ", "score": 1, "replies": [], "tickers": [], "relates_score": 0.3778921067714691}, {"body": "Crypto mining downfall.  ", "score": 1, "replies": [], "tickers": [], "relates_score": 0.3180083632469177}, {"body": "Yep, day trading profit takers and market makers will do this for you.", "score": 1, "replies": [], "tickers": [], "relates_score": 0.20077751576900482}, {"body": "Nvidia  **ALWAYS bounces** around\n\nMeme stock", "score": 1, "replies": [{"body": "Lol, there is only one MEME stock and it\u2019s AMD.\n\nOr SQ or MU....lol", "score": 1, "replies": [], "tickers": ["amd"], "relates_score": null}], "tickers": ["nvda"], "relates_score": null}, {"body": "Relative noob here. Do I buy 2 shares of this now or wait?", "score": 1, "replies": [], "tickers": [], "relates_score": 0.2752806544303894}, {"body": "Everyone is so hung up on this idea that if it beats on earnings, then it *must* go up. That's not true. That's not how it works. Everybody got it now? Great.", "score": 1, "replies": [{"body": "How does it work then? ", "score": 1, "replies": [{"body": "That is the subject of a thesis, not a reddit post. But you have to take the entire report and price into account, the entire report and price relative to expectations, competitors, past performance, current market trends, price action before earnings, history of price action before previous reports, macroeconomic factors, and how emotional investors (institutional and homegamers) react to all those factors all at the same time.", "score": 1, "replies": [], "tickers": [], "relates_score": 0.01806269772350788}], "tickers": [], "relates_score": 0.12215107679367065}], "tickers": [], "relates_score": 0.670252799987793}, {"body": "A lot of people jumped on the stock just to ride the latest crypto currency bubble. Those same people think that bubble might have peaked and are now jumping back off.\n\nThey weren't in it for the long term to begin with. Good riddance. Nvidia has a lot going for it across the tech industry, not just crypto.", "score": 2, "replies": [{"body": "Crypto will seem so silly soon, the power nvda is now putting out will drive ai. that is where to look ahead. Although I predict that to eventually ai may be very similar to the block chain concept, as scary as that is.", "score": 3, "replies": [], "tickers": ["nvda"], "relates_score": null}], "tickers": ["bubble", "nvda"], "relates_score": null}, {"body": "No shit dude. It was up over 10% in one week", "score": 1, "replies": [], "tickers": [], "relates_score": 0.4550212621688843}, {"body": "[deleted]", "score": 1, "replies": [{"body": "Lol, yeah right. 150b market cap being manipulated or an simple after hours reaction to earnings. Has to be the first because the second is just ridiculous.", "score": 1, "replies": [], "tickers": [], "relates_score": 0.08343662321567535}, {"body": "It isn't market manipulation.  That's BS. On the conference call they indicated crypto-related business would be way down. They also disclosed how big that business is.", "score": 1, "replies": [], "tickers": [], "relates_score": 0.022944938391447067}], "tickers": [], "relates_score": 0.08604494482278824}, {"body": "This was the most obvious sell the earnings this season.... guys, seriously?", "score": -3, "replies": [{"body": "lol \"seriously\" not what you just said just yesterday https://www.reddit.com/r/stocks/comments/8i0h8z/nvda_is_a_screaming_short_going_into_earnings/dyop4jo/?context=3\n", "score": 6, "replies": [{"body": "How much money did you lose bro? Sounds like a lot if you dig through my post history.\n\nI host online courses for $399.99 weekly if you are interested. Crypto included.\n\nBro, post pics of your losses ", "score": -4, "replies": [], "tickers": [], "relates_score": 0.26571622490882874}, {"body": "Ps- I just read your link, me admitting we are in a bull market has nothing to do with NVDA. You kidding me? How fucking retarded are you? LOL!!!!", "score": -7, "replies": [], "tickers": ["nvda"], "relates_score": null}, {"body": "[deleted]", "score": -7, "replies": [{"body": "I know how it feels to loose a bunch of money, it will be alright man.", "score": 5, "replies": [], "tickers": [], "relates_score": 0.05599622428417206}], "tickers": [], "relates_score": 0.09416498988866806}], "tickers": [], "relates_score": 0.420701265335083}], "tickers": [], "relates_score": 0.5370872020721436}, {"body": "Think of it like this:\n\nIf eps = $1.47 then share price should be 230\n\nIf eps = $1.98 then share price should be 250\n\nIf eps = $2.50 then share price should be 270\n\n\nNow ask yourself why did the stock price drop if eps was 1.98....", "score": -1, "replies": [{"body": "Super noob question...\n\nHow do you calculate that?", "score": 1, "replies": [{"body": "Step one put hand up ass, step two pull these numbers out.  ", "score": 4, "replies": [{"body": "Figured as much", "score": 1, "replies": [{"body": "Sorry. I thought it would be obvious the numbers were made up. I just wanted OP to understand 1 possible reason for the drop since he seemed to be clueless... ", "score": 3, "replies": [], "tickers": [], "relates_score": 0.24990074336528778}], "tickers": [], "relates_score": 0.07327975332736969}], "tickers": [], "relates_score": 0.2681662440299988}, {"body": "Its just an example to illustrate a point", "score": 2, "replies": [], "tickers": [], "relates_score": 0.03551339730620384}], "tickers": [], "relates_score": 0.2714307904243469}], "tickers": [], "relates_score": 0.606320321559906}], "tickers": ["nvda", "nvda"]}
{"title": "This EXEL dip is the buying opportunity of the century", "selftext": "I have posted before on $EXEL after their most recent earnings and I firmly believe fair value is around $40-50 per share.\n\n[This morning they announced that a trial Genentech was conducting for a drug combination for the treatment of colorectal cancer failed](https://www.google.com/amp/s/mobile.reuters.com/article/amp/idUSASC0A1A9)\n\n[For a nice visual representation of the absurdity of this sell off...](https://m.imgur.com/a/qOqpD9G) \n\nThat tiny blue blip is Cometriq. Constituting 2% of overall revenue, while Cabozantinib represents the majority of revenue, growing at a 100% rate YoY. Cometriq, literally means nothing to EXEL besides an FDA approved drug they are keeping in their pocket. Its like of Apple sold off 15% because of weak stylus sales. \n\nThis is a great buying opportunity for a great company with a drug that is blowing every Tyrosine Kinase Inhibitor it is compared against out of the water. The company is trading at the same levels it was a year ago, despite over 100% growth in their leading franchise and 600% overall earnings growth. \n\nCorrection: I got names mixed up. The results from today assess Cotellic. Not Cometriq. Cotellic makes no current contribution to the revenue stream. ", "id": "8ij8x7", "created_utc": 1525994659.0, "score": 46, "upvote_ratio": 0.9, "num_comments": 118, "comments": [{"body": ">I firmly believe fair value is around $40-50 per share\n\nHow'd you get to that number?", "score": 12, "replies": [{"body": "his $30 buy-in plus $10 for two boxes of tendies.", "score": 49, "replies": [], "tickers": [], "relates_score": 0.36037763953208923}, {"body": "Assuming a halt in the growth of Cabozantinib, 40-50 would represent a PE of about 27-34 assuming no growth. I expect growth to continue at a relatively reduced rate, but if it continues at a comparable rate (which is reasonable to assume given recent first line RCC approval), PE at 40-50 would be about 13-18. \n\nAlso, that represents about 10x expected FY18 revenue which is a reasonable valuation for a biopharm operating at 55% net margin. ", "score": 7, "replies": [{"body": "Its a BIO, no BIO trades at 27-34 PE....\nThat isn't how you calculate fair value on a BIO either.  /Yawn\n", "score": -1, "replies": [{"body": "I was asked about my price target. I gave 2 of the most popular valuation methods to justify my price target. \n\nFuck off. ", "score": 16, "replies": [{"body": "Those valuation methods aren't for BIOs ;) I know its hard bro, but do at least some basic research~ ", "score": 1, "replies": [], "tickers": [], "relates_score": 0.34602782130241394}], "tickers": [], "relates_score": 0.280131071805954}], "tickers": [], "relates_score": 0.4544295370578766}], "tickers": [], "relates_score": 0.391746461391449}], "tickers": [], "relates_score": 0.5241886973381042}, {"body": "wait isn't cabozantinib just Cometriq and Cabometyx? ", "score": 6, "replies": [{"body": "No. \n\nCabozantinib brand name = Cabometyx\n\nCotellic brand name = Cometriq\n", "score": 1, "replies": [{"body": "No I think you mean cabozantinib is cabometyx and cometriq\nhttps://en.wikipedia.org/wiki/Cabozantinib\n\nCobimetinib is what failed. maybe the slide they provided is just wrong. contellic is on the market but if the combo trial was a success it would have expanded the patient pool ", "score": 3, "replies": [{"body": "You are absolutely correct... but you made my point even stronger.\n\nCotellic/Cobimetinib was the drug being tested and I got mixed up thinking Cometriq was the drug being tested but Cotellic/Conometinib currently makes no current contribition to the revenue breakdown", "score": 4, "replies": [], "tickers": [], "relates_score": 0.6367160081863403}], "tickers": [], "relates_score": 0.7588398456573486}, {"body": "Lol definitely a bag holder that doesn\u2019t actually understand what he got himself into", "score": 3, "replies": [{"body": "[HELP ME THESE BAGS ARE TOO HEAVY](https://imgur.com/a/YVbXR5f)", "score": 13, "replies": [{"body": "You got me there, can\u2019t really talk shit to the guy throwin around 70% screen shots. I\u2019ll toss 1k into calls ", "score": 7, "replies": [{"body": "<3 Sorry if I am being a dick but I am really not pumping and I truly think I am right. \n\nI really am just posting cause I think its a good idea and I want to contribute to you guys making money. Of course I may be wrong but I tried to give some baseline DD at the least so that you guys will do your own DD and make your own call on it. ", "score": 4, "replies": [{"body": "Kinda my fault too I like to take a contrarian stand point regardless of what the topic is cause arguing is fun", "score": 4, "replies": [{"body": "I will say though, Id consider some of the DD that pops up around here. I got in on BXC and NTNX before their big runs based on WSB DD", "score": 2, "replies": [], "tickers": [], "relates_score": 0.035153020173311234}, {"body": "Oh same. I had a great time arguing my point", "score": 1, "replies": [{"body": "Yo my guy I bought some weekly EXEL calls last week that are up 200% rn I was wrong you were right and I can\u2019t thank you enough for showing me this company", "score": 5, "replies": [{"body": "Glad to hear it. Good on you for being skeptical but open minded! ", "score": 2, "replies": [], "tickers": [], "relates_score": 0.1881573349237442}], "tickers": [], "relates_score": 0.1356186717748642}], "tickers": [], "relates_score": 0.5671886801719666}], "tickers": [], "relates_score": 0.18156000971794128}], "tickers": [], "relates_score": 0.23306003212928772}], "tickers": [], "relates_score": 0.03779285028576851}], "tickers": [], "relates_score": 0.3166694641113281}, {"body": "Dude... my mistake stengthens my inital point. Also current average cost is 19.61 for 300 shares I am holding using the profits I made from calls I sold for a 150% return after the earnings pop. ", "score": 2, "replies": [{"body": "Dude... just trade tech ", "score": 1, "replies": [{"body": "I like to pretend to use my degree in biology. Do you need a picture of that too for proof?", "score": 6, "replies": [{"body": "Dawg I\u2019m buying calls you got me ", "score": 3, "replies": [], "tickers": [], "relates_score": 0.14589479565620422}], "tickers": [], "relates_score": 0.06697315722703934}, {"body": "Fuck tech bio all day", "score": 2, "replies": [], "tickers": [], "relates_score": 0.3826238214969635}], "tickers": [], "relates_score": 0.1613810807466507}], "tickers": [], "relates_score": 0.10766221582889557}], "tickers": [], "relates_score": 0.035055626183748245}], "tickers": [], "relates_score": 0.8362324237823486}], "tickers": [], "relates_score": 0.23955704271793365}, {"body": "These numbers add up I like this.  I have a G laying around doing nothing I might throw it at this tomorrow.", "score": 6, "replies": [{"body": "I am on the verge of all inning my account. This is the biggest opportunity I think I've ever found", "score": 2, "replies": [{"body": "I think your 40-50 may be a little high but we\u2019re definitely undervalued here", "score": 3, "replies": [{"body": "That's very fair. I am basing that partly on my belief that Cabo is the most effective TKI drug on the market and that valuation would likely include approval for treatment of HCC (liver cancer). ", "score": 3, "replies": [{"body": "I\u2019m with you there.  Another indication would put it in that kind of p/e range.  As long as current growth rate doesn\u2019t slow tooooo dramatically.", "score": 2, "replies": [], "tickers": [], "relates_score": 0.3929230868816376}], "tickers": [], "relates_score": 0.330554336309433}], "tickers": [], "relates_score": 0.18765117228031158}, {"body": "i dig this, might also all-in with you. such an insane earnings beat that didn't do much for the share price. gunna do more research and hit you up. this is some good shit OP, some good shit! gunna read the conference call later, how was guidance?", "score": 2, "replies": [{"body": "I haven't exactly figured out why but EXEL management doesn't provide guidance on quarterly reports. They presented positive outlook but no firm guidance. \n\nCome back and let me know what you find! I enjoy discussing these things. ", "score": 1, "replies": [{"body": "good call my dude. have been in the MU run up (of course) so didn't get to take advantage of this yet, but will add eventually. check out BITA. gunna compile a long DD post about it once the next earnings comes out. It has a market cap of ~1.5B compared to its competitor with ~11B despite higher revenues and a projected return to profitability", "score": 1, "replies": [], "tickers": [], "relates_score": 0.33209896087646484}], "tickers": [], "relates_score": 0.44912636280059814}], "tickers": [], "relates_score": 0.33313801884651184}], "tickers": [], "relates_score": 0.29922834038734436}], "tickers": [], "relates_score": 0.11737611144781113}, {"body": "What are your thoughts on the imblaze370 trials not meeting expectations", "score": 8, "replies": [{"body": "I think it couldn't possibly mean any less. This is the point of my post. The drug used in the trial represents 2% of revenue. Even if they decided to scrap the drug it wouldn't mean anything given the massive growth in the Cabozantinib franchise.\n\nIn addition, the drug combo was used on patients that already failed 2 or more chemo regimens in the famously difficult to treat colorectal cancer and they needed to prove a positive effect over current treatment standards. This doesn't even mean the drug is bad. Gerentech (This wasnt even an EXEL-led trial) just couldnt prove that the combo was more effective than Stivarga. The drug is still approved for Melanoma, not that it matters because Cabozantinib contributes the overall majority of revenue. ", "score": 6, "replies": [{"body": "Options seem pretty pricey. Overall it looks like a buy and hold scenario?", "score": 3, "replies": [{"body": "Yep, the call to put interest ratio is something like 6000-800 last I heard. \n\nI think August calls look pretty damn juicy right now because I think a buyout is possible (I'd say 20% chance, but thats just a made up number) but I think its pretty grossly undervalued with current financials regardless and I expect the market to correct itself pretty quickly given the incredible results and uniformly positive analyst coverage. ", "score": 3, "replies": [{"body": "I\u2019d love to buy a few contracts but unfortunately I\u2019m a small fish in a large pond. Can\u2019t lock up all of my 2k in August calls. \n\nI will say that I think your dd is solid, and if I had the capital I\u2019d buy a few contracts just to see what happens. So you\u2019ve got my +1 if that means anything\n\nEdit: I also wonder how mush lower this will drop due to the failed drug. Perhaps it will be even more of a steal.", "score": 2, "replies": [{"body": "Yep. Do what you think is best.\n\nJust putting it out there though, a $25 call for August is $58. That would be a 4.35x ($692) return if they make it make to their 52 week high, which I think is easily deserved and certainly attainable. And that only used about 3% of your portfolio. Of course you should do what you are comfortable with, but just presenting an option. ", "score": 2, "replies": [{"body": "Answer  me this (please): why is it more profit to buy that call than the more expensive 19 call, assuming the stock price meets the break even 25$ mark.\n\nIsn\u2019t it safer and more money overall to buy the 19 even with the increased premium?\n\nEdit: I\u2019m new to options.", "score": 2, "replies": [{"body": "No. This is pretty tricky to explain but I'll try.\n\nOptions are exercisable up to their expiration, therefore, the $19 call has a much higher value than the $25 because it is more likely that it will be exercisable for a profit since it only requires a 2% increase. \n\nThe $25 call is less likely to be exercisable since it is further from current share price therefore, since the probability is lower, the price is deflated.\n\nAny call above current share price has a notional value based on probability. Since 25 is less likely, you get a 8.6 times return if it makes it to 30, while if it makes it to 30 but you buy a 19, you get a 5.16 times return. And that inflates as you move up. If it makes it to 40, a 25 would yields a 25.86 return while a 19 yields a 9.86 return and that gap grows the higher it goes. \n\nI hope that made some sense and I hope I didn't mix up any numbers and I am doing this all on my shitty Samsung galaxy. \n", "score": 6, "replies": [{"body": "Exponential return based on risk. Got the what, but what about the why?\n\nLike who is going to buy my call if the premium is that high? Are they still guaranteed a solid profit?", "score": 2, "replies": [{"body": "Yes. There is implied call value and actual call value.\n\nActual call value=share price-strike price\n\nYou will always be able to sell a call for actual call value at minimum, even on expiration Friday because it is not a theoretical value if it is above strike price. ", "score": 3, "replies": [{"body": "I'm not the og questioner but this been really helpful in to me flushing out my understanding of options! Thank you! ", "score": 2, "replies": [], "tickers": [], "relates_score": 0.0733853429555893}, {"body": "Does this apply to puts as well? Somewhat new to options and lately I\u2019ve been wondering, what happens if I home run slam 100 puts out of the park for like an 800% gain each but no one is willing to buy the puts once I put in the market order? Can they just expire worthless even if you put in the market sell the morning of the last trading day?", "score": 1, "replies": [{"body": "The way options work is the are priced for probabilities basically and they have 2 values. Theoretical and actual.\n\nA put below the share price always has an actual value of 0. \n\nA put above the share price has an actual value of Strike-Share price. \n\nA put ABOVE share price will, at all times, before greater than or equal to actual value. ", "score": 1, "replies": [{"body": "Okay, so my $1 put with a stock that is trading at .80 has real value and is guaranteed to sell when I sell it\u2014literally?\n\nVersus my $1 put on a stock that is $1.05\u2013maybe I bought that put two weeks ago and it technically has more equity now, in that I could sell it to close for a profit, but since it\u2019s theoretical value there exists a possibility that no one would buy it from me?", "score": 1, "replies": [{"body": "Well that question gets to how options are priced (stocks are the same but its less of a consideration)\n\nThere are 3 prices associated with an option, bid, ask, mark. Bid is the highest price someone is asking to buy for. Ask is lowest anyone is selling for. Mark is the midpoint. You will always be able to sell at the bid at least.", "score": 1, "replies": [], "tickers": [], "relates_score": 0.5096287131309509}, {"body": "But to answer your question, yes you can get stuck with an option if no one wants it but that only happens when an option is so cheap (which indicates improbable to profit), the entire market considers it worthless and no one wants it. I have some CBOE calls in that situation right now", "score": 1, "replies": [{"body": "It can also happen in an illiquid option chain. ", "score": 1, "replies": [], "tickers": [], "relates_score": 0.46553942561149597}], "tickers": [], "relates_score": 0.3705412745475769}], "tickers": [], "relates_score": 0.6586410999298096}], "tickers": [], "relates_score": 0.5159608125686646}], "tickers": [], "relates_score": 0.3475055992603302}], "tickers": [], "relates_score": 0.185059055685997}], "tickers": [], "relates_score": 0.35520392656326294}, {"body": "Hi cdupree,\n\ncan you tell me the tools that you use to calculate the returns? or the maths behind it, if you have the time.\n\n\n\n> from current share price therefore, since the probability is lower, the price is deflated.\n> \n> Any call above current share price has a notional value based on probability. Since 25 is less likely, you get a 8.6 times return if it makes it to 30, while if it makes it to 30 but you buy a 19, you get a 5.16 times return\n\n", "score": 1, "replies": [{"body": "For a call, the ACTUAL value, meaning what it is worth at a given share price is equal to [(share price)-(strike price)] and reverse that for puts. The goal is to buy them when they are significantly below what you anticipate the ACTUAL value may be before the expiration date. \n\nI have a google spreadsheet with formulas set up to track this, which I would recommend trying because it can be very helpful for visualizing what you are actually buying. \n\nBeware, my numbers in that comment though may be off because I was doing the math on my cell phone at the time I was commenting. ", "score": 2, "replies": [{"body": "Thank you for replying, I was interested to know the how you got the return percentage/multiplier, I assumed you calculated it like this? --> ((shareprice-strikeprice)/(call premium))", "score": 1, "replies": [{"body": "Correct. ", "score": 1, "replies": [{"body": "Thank you sir, I owe u.", "score": 1, "replies": [], "tickers": [], "relates_score": 0.15955345332622528}], "tickers": [], "relates_score": 0.08643662929534912}], "tickers": [], "relates_score": 0.2957741916179657}], "tickers": [], "relates_score": 0.37891122698783875}], "tickers": [], "relates_score": 0.6353838443756104}], "tickers": [], "relates_score": 0.6667629480361938}], "tickers": [], "relates_score": 0.5175834894180298}], "tickers": [], "relates_score": 0.5112107992172241}], "tickers": [], "relates_score": 0.511282742023468}], "tickers": [], "relates_score": 0.613457202911377}], "tickers": [], "relates_score": 0.208485409617424}], "tickers": [], "relates_score": 0.5396381616592407}], "tickers": [], "relates_score": 0.35012924671173096}, {"body": "You almost have me convinced. Juat answer this yet: why are insiders selling?\n\nhttps://marketexclusive.com/analyst-activity-piper-jaffray-lowers-its-price-target-on-nasdaqexel-exelixis-nasdaqexel-to/2018/05/\n\nEDIT: Just read this article and I'm in for the ride:\n\nhttps://www.zacks.com/commentary/161787/bull-of-the-day-exelixis-exel?cid=CS-CNN-HL-161787", "score": 3, "replies": [], "tickers": [], "relates_score": 0.6157959699630737}, {"body": "Sweet. I\u2019ll look at the call options tomorrow and pick up a contract. If it goes well enough I guess I\u2019ll owe you a bottle of scotch.", "score": 3, "replies": [], "tickers": [], "relates_score": 0.1935134381055832}, {"body": "Bought calls on Friday and they\u2019re already up 50%. Thanks for the fantastic DD m8", "score": 3, "replies": [{"body": "This make me very happy to hear. It is truly gratifying to actually help someone make money just by sharing an idea. \n\nI'll keep posting my best ideas as I find them!", "score": 2, "replies": [], "tickers": [], "relates_score": 0.2176167070865631}], "tickers": [], "relates_score": 0.2643856406211853}, {"body": "Hey man, thank you very much for the tip-off. I've been subscribed to this sub-reddit for almost a year now ( mostly for jokes) and this is the first solid advice that I have seen here.\n\nBought 20k worth on Friday, up 1k already! ", "score": 3, "replies": [{"body": "Glad to help! Keep scanning new posts. I promise some good DD pops up every now and again, it just rarely makes it to the front page. I got some big wins on NTNX and BXC off WSB tips. ", "score": 2, "replies": [{"body": "Nice, I\u2019ll follow you from now on in case you got some more DD goodness :). \nI mostly just lurk, but I got one for you- GC.TO  this company is going to be building a giant casino in my city ( the only one mind you aside from random slots).  Toronto has a huge population with a significant Asian community who are disproportionately insane gamblers for some reason. This thing will take off to the moon within 5 years ( the time it takes to build the casino). They also own a ton of Canadian and a few American casinos already and are generating great revenue ( I\u2019m up 50% on them already). \n  Look into them :) ", "score": 1, "replies": [], "tickers": [], "relates_score": 0.44639092683792114}], "tickers": [], "relates_score": 0.45620104670524597}], "tickers": [], "relates_score": 0.23000571131706238}, {"body": "[deleted]", "score": 2, "replies": [{"body": "I have no knowledge of any TKIs in development but I am currently researching but haven't found anything. ", "score": 1, "replies": [{"body": "[deleted]", "score": 1, "replies": [{"body": "The chart describes that pretty well too. That is basically the result of a QoQ decrease in earnings and revenue in a rapid growth company that had developed a reputation for beating estimates and that quarter they reported in line with expectations for the first time in a while. ", "score": 1, "replies": [], "tickers": [], "relates_score": 0.025992803275585175}], "tickers": [], "relates_score": 0.019415078684687614}], "tickers": [], "relates_score": 0.019415078684687614}, {"body": "What I can say though is EXEL has entered a partnership for the development of novel biologics to treat cancer.\n\nBiologics are just much more complicated drugs, generally coming from something like a modified yeast population with much longer profittable lifetimes. Just to note EXEL is using profits to create new opportunities and build their pipeline so they aren't so Cabo dependent. Even though Cabo is pretty incredibly successful.", "score": 1, "replies": [], "tickers": [], "relates_score": 0.008000844158232212}], "tickers": [], "relates_score": 0.041480958461761475}, {"body": "sign me up coach, whats calls and what expiry?", "score": 2, "replies": [{"body": "I like August $25s. Captures next ER and gives some time for the chance of a buyout, which would be at $35 minimum (if lower I will be personally involved in the lawsuit for undervaluing the sale of the shares)", "score": 2, "replies": [], "tickers": [], "relates_score": 0.2274864912033081}], "tickers": [], "relates_score": 0.038775622844696045}, {"body": "I'm in for ten calls, if you're right I'll get you a shirt or something", "score": 2, "replies": [{"body": "I recommend letting it settle first just to make sure the algorithms have calmed down. \n\nEXEL is primarily held by institutions and I am pretty confident most of today's selling was an algorithms response to a \"failed trial\" headline. \n\nJust watch how it looks tomorrow morning before pulling the trigger to get max return value. ", "score": 1, "replies": [], "tickers": [], "relates_score": 0.132381409406662}], "tickers": [], "relates_score": 0.06637893617153168}, {"body": "What do you make of all the consistent insider share sales over the last few months as shown on finviz? Seeing that sort of thing makes me have less faith in a company\u2019s growth since the execs seem to lack that same faith", "score": 2, "replies": [{"body": "Im not happy about it but that is misleading. These sales are the result of executives exercising options that expire this month. They arent liquidating positions. They are exercising the options and selling what they bought in the exercise. Not happy about them increasing the float but can investors really complain with this type if fiscal performance? ", "score": 1, "replies": [], "tickers": [], "relates_score": 0.6440823674201965}], "tickers": [], "relates_score": 0.4605599641799927}, {"body": "I dipped in and am up 30% already. Thanks OP", "score": 2, "replies": [{"body": "Happy to help! I'll continue posting my favorite plays as I find them. ", "score": 1, "replies": [], "tickers": [], "relates_score": 0.20754440128803253}], "tickers": [], "relates_score": 0.3213599920272827}, {"body": "Good find you cuck. Why has it been trading sideways all year if the growth is so amazing?", "score": 2, "replies": [{"body": "Also, part of it is because Cramer called them a \"speculative developmental stage company\". \n\nApparently a company with 100% growth, a PE in the 20s, and 500 million cash with no debt is speculative?", "score": 4, "replies": [{"body": "Who the fuck listens to Cramer. His average return is like 4.1% a year and his show is what? Basically yelling about stonks for an hour? I've never seen it", "score": 3, "replies": [], "tickers": [], "relates_score": 0.4234761893749237}], "tickers": [], "relates_score": 0.45766904950141907}, {"body": "Their last earnings report (Q4 FY17) met expectations after some major beats. This suggested a slow down Cabozantinib sales until they achieved first line RCC approval and their most recent earnings report which beat estimates by a factor of 3. It popped off earnings, but then got held back because management suggested bad results for the trial with Gerentech. The failed trial cause a 15% sell off today, despite the fact that failure has no material impact on revenue or earnings. ", "score": 1, "replies": [{"body": "Failure has impact on future earnings which is all anyone cares about, if all their drugs are failing tests they have no new streams of revenue and will stagnate or drop", "score": 4, "replies": [{"body": "Buddy. I linked a chart that explains my point. See the blue one that is going down slowly? That is Cometriq. See the red one that is growing very quickly? That is Cabozantinib/Cabometyx. \n\nThink of it this way. Cabo is their many growth area/product so think of it as their \"iPhone\". Cometriq is a drug that is fda approved but not very profitable so think of it as an \"Apple Stylus\". Just cause it is not selling well as 2% of revenue doesn't mean anything. If everyone decides Cometriq sucks and doesn't want to use it in trials anymore, ok, that is a 2% hit EXELs revenue takes. But, Cabo is growing over a 100% YoY and it is being evaluated for expanding indications and recently got approved for all levels of kidney cancer, suggesting, growth of that big red bar will continue. ", "score": 5, "replies": [{"body": "Ok now think about this, Apple doesn\u2019t make a new iPhone cause none of them work, they\u2019re only riding along on the hopes that their sales continue to rise with no new innovation. How the fuck would that drug even be able to affect revenue if they\u2019re still testing it of course t isn\u2019t a large percent, the issue is it\u2019s supposed to be in the future and it doesn\u2019t look like that\u2019s going to happen. Is that easy enough to understand", "score": 0, "replies": [{"body": "They already discovered their iPhone. Its cabozantinib which just got approval for 1st line RCC (kidney cancer). They are sitting at 25% market share and outperforming every other TKI in the market. If they can continue to penetrate the market at a comparable rate, they will quadruple revenue and earnings in the next year. ", "score": 7, "replies": [{"body": "You got me fag . What is the timeline we are looking at ? When do we expect this bitch to get up to 40-100", "score": 6, "replies": [{"body": "Of course I can only predict, but, I think with current financial standing and performance results its worth $35 right at this moment and I think an approval for liver cancer (HCC) would rocket us over $100 since that is a massive market. \n\nI believe it will be 40+ by August, but I am just another cuck making predictions. ", "score": 6, "replies": [], "tickers": [], "relates_score": 0.24294576048851013}], "tickers": [], "relates_score": 0.15677234530448914}], "tickers": [], "relates_score": 0.5945354104042053}], "tickers": ["aapl"], "relates_score": null}], "tickers": ["aapl"], "relates_score": null}], "tickers": [], "relates_score": 0.5931938886642456}], "tickers": [], "relates_score": 0.47240400314331055}], "tickers": [], "relates_score": 0.40153223276138306}, {"body": "What's the catch? Too good to be true", "score": 2, "replies": [], "tickers": [], "relates_score": 0.18806909024715424}, {"body": "When\u2019s next earnings call?", "score": 1, "replies": [{"body": "First week of August", "score": 1, "replies": [], "tickers": [], "relates_score": 0.45078662037849426}], "tickers": [], "relates_score": 0.33062610030174255}, {"body": "Their drug just failed a phase 3 trial. Not sure where bottom will be", "score": 1, "replies": [{"body": "Mate... this is the point of my post. \n\nThe drug that failed contributes 0% of revenue. (My inital statement was inaccurate, Cometriq was not the drug tested, rather Cotellic.) Cotellic is not included in the revenue stream.\n\nTheir headlining product composing literally 100% of revenues is the growth driver here. It is recently approved for all stages of kidney cancer (RCC) and has been very clinically effective. The results today do not matter because even if the trial did succeed, that is not what matters. EXEL is undervalued with its CURRENTLY effective and proved drugs. \n\nAnd on top of that Cabo is theoretically effective as a therapy in virtually all tumor based cancers as it acts as a tyrosine kinase inhbitor which is a drug that is meant to prevent tumor metastasis. They are currently pursuing approval for liver cancer (HCC) but lets revisit the main point. BUT IT DOESN'T MATTER BECAUSE THEY ARE ALREADY BRINGING IN A FILTHY AMOUNT OF CASH. \n\nDo you get what I am trying to say?", "score": 3, "replies": [{"body": "Oh I get it and i agree it is undervalued. The problem is convincing this idiotic market that is all about over valued tech stocks ", "score": 1, "replies": [], "tickers": [], "relates_score": 0.2973277270793915}], "tickers": [], "relates_score": 0.5767895579338074}], "tickers": [], "relates_score": 0.46987929940223694}, {"body": "\ud83e\udd14 I know dickall about bio tech.   \n    \nBut, if EXEL is so great, why wasn't Lord Shkreli pumping it in *This week in Investing* before we went to prison pound town?", "score": 1, "replies": [{"body": "This doesn't require an understanding of biotech. Just an understanding that these are seperate drugs.\n\nAnd that is because he has been in jail since before the recent developments but now that you mention it, I think this may interest him a lot actually. I may mail him some research papers I have on $EXELs drugs and the last year of reports to get his thoughts. ", "score": 3, "replies": [{"body": "Hey, cdupree1, just a quick heads-up:  \n**seperate** is actually spelled **separate**. You can remember it by **-par- in the middle**.  \nHave a nice day!\n\n^^^^The ^^^^parent ^^^^commenter ^^^^can ^^^^reply ^^^^with ^^^^'delete' ^^^^to ^^^^delete ^^^^this ^^^^comment.", "score": 1, "replies": [], "tickers": [], "relates_score": 0.04011888429522514}], "tickers": [], "relates_score": 0.46016448736190796}], "tickers": [], "relates_score": 0.4811494052410126}, {"body": "I like this.. If my MTCH calls go according to plan and EXEL is still a value buy next week, I'll sell my juicy calls and buy in EXEL. I think it's worth the dice roll. This looks really good. If I didn't have the money in other stocks right now, I'd buy 50-100 $19 calls expiring June 15th. What kind of time frame are you thinking?\n\nWe'll see if it's still a good deal next week.", "score": 1, "replies": [], "tickers": [], "relates_score": 0.5392499566078186}, {"body": "So August 25s are the play here?", "score": 1, "replies": [], "tickers": [], "relates_score": 0.07893006503582001}, {"body": "TRUMP TO DELIVER SPEECH ON LOWERING DRUG PRICES AT 2PM FRIDAY.   Now what?", "score": 1, "replies": [], "tickers": [], "relates_score": 0.12141718715429306}, {"body": "Sounds like that post about RAD. Remember RAD?", "score": 1, "replies": [], "tickers": [], "relates_score": 0.032554060220718384}, {"body": "As much as this sounds great I know shit all about biotechnology so I'll be staying away from this one", "score": 1, "replies": [], "tickers": [], "relates_score": 0.13603346049785614}, {"body": "whats your position on this? ", "score": 1, "replies": [{"body": "300 shares and a variety of August calls", "score": 1, "replies": [{"body": "nice -- thanks for the DD. Just bought some August 25c. Read up on some of their scientific literature as well, looks pretty legittttttttttttttttt", "score": 2, "replies": [], "tickers": [], "relates_score": 0.2019025832414627}], "tickers": [], "relates_score": 0.028056295588612556}], "tickers": [], "relates_score": 0.16616539657115936}, {"body": "Picked up 5 Aug 25C and 2 Jan 25 leaps. Barely $700 total so I figured why not play along, seems like decent DD.", "score": 1, "replies": [], "tickers": [], "relates_score": 0.27570345997810364}, {"body": "Which calls are you looking into buying? Are you not worried about the high IV?", "score": 1, "replies": [], "tickers": [], "relates_score": 0.2761378884315491}, {"body": "got some june and aug calls. doing pretty well today", "score": 1, "replies": [], "tickers": [], "relates_score": 0.33192208409309387}, {"body": "Got in mid morning today after it looked like it stabilized right around 18.99. Up 4%. Lets hope the trend continues! \n\nThanks for an insightful post!", "score": 1, "replies": [], "tickers": [], "relates_score": 0.3815147578716278}, {"body": "Dude, great find. I'm already up $30 \ud83d\ude02\ud83d\ude02\ud83d\ude02", "score": 1, "replies": [], "tickers": [], "relates_score": 0.2343447059392929}, {"body": "[deleted]", "score": -1, "replies": [{"body": "stfu man. this guy is trying to contribute to this subreddit, not post autistic garbage like you are right now.", "score": 9, "replies": [{"body": "I think I'm gay now because I love you. ", "score": 2, "replies": [{"body": "F", "score": -2, "replies": [], "tickers": [], "relates_score": 0.1666313260793686}], "tickers": [], "relates_score": 0.12098390609025955}, {"body": "[deleted]", "score": -3, "replies": [{"body": "GTFO", "score": 6, "replies": [], "tickers": [], "relates_score": 0.22068816423416138}], "tickers": [], "relates_score": 0.1497253179550171}], "tickers": [], "relates_score": 0.1497253179550171}, {"body": "We are talking 5.5 billion market cap. If he wanted to pump something there are way better stocks to do that too", "score": 5, "replies": [{"body": "And a 25 PE ratio that was in the 50s last week. ", "score": 1, "replies": [{"body": "Exactly! This market was comfortable trading this company at a PE double what it is now literally a couple weeks ago that only got cut in half because they made so much money. This sell off was utterly ridiculous. ", "score": 1, "replies": [], "tickers": [], "relates_score": 0.30835968255996704}], "tickers": [], "relates_score": 0.20422595739364624}], "tickers": [], "relates_score": 0.0847475603222847}, {"body": "$500 Million cash. No debt. 25 PE ratio. Over 100% growth rate. If that doesn't sound good to you, you don't know how to do DD. ", "score": 2, "replies": [{"body": "Their fundamentals do look brilliant, I had to sell my 6/15's at a big loss, hoping my 1/18/19 $23's come around. I feel like there's better opportunities on LEAP calls and ER runnups this week so I sold my shares at a chunky loss. ", "score": 1, "replies": [{"body": "I am so sorry if you bought based on my last post and I cucked you like that. \n\nI really so believe this drop is a mistake based on panic (or algorithms that sell based on news like failed trials, no matter how inconsequential they may be). I firmly believe your leaps will yield great profits and if you can buy the dip you will likely be rewarded.", "score": 2, "replies": [{"body": "I  went and checked out the 10-Qs and honestly it's a raving buy from the financials. Not entirely your fault.   I've been doing quite well on options so I moved some of it into there. I believe the 1/18/19s have a decent chance of making up the other losses.", "score": 3, "replies": [], "tickers": [], "relates_score": 0.5696369409561157}], "tickers": [], "relates_score": 0.5255228281021118}], "tickers": [], "relates_score": 0.2944462299346924}], "tickers": [], "relates_score": 0.027003929018974304}], "tickers": [], "relates_score": 0.041480958461761475}], "tickers": ["aapl"]}
